Rocket Lab's Space Force Win Fuels Ambition, But Profit Estimate Cuts Cloud the Picture

Rocket Lab reports 63.5% revenue growth to $200M but $45M net loss; $2.2B backlog from U.S. government contracts; analyst split: Zacks sell vs. 18 brokerages buy.

The contradiction at the heart of Rocket Lab's market narrative has rarely been starker. The company is piling up government contracts and stuffing its order book to a record $2.2 billion, yet analysts are slashing earnings forecasts at a pace that raises eyebrows. The stock has surged 347% over twelve months, but the air around it feels thinner with each passing week.

Revenue tells a promising story. In the first quarter of 2026, Rocket Lab posted $200.3 million in sales — a 63.5% jump from the prior year. That followed a full-year 2025 revenue of $680 million, itself up 46%, and analysts expect another 52% gain for the current year. The backlog swelled 20.2% quarter over quarter, hitting that $2.2 billion milestone. Yet the bottom line remains stubbornly red: a net loss of $45 million in Q1, though an improvement from $60.6 million a year earlier. For the current quarter, management guides revenue between $225 million and $240 million, but still sees negative adjusted EBITDA of $20 million to $26 million.

That gap between top-line momentum and bottom-line reality has split the analyst community. Zacks downgraded the stock to a "Sell" (rank 4 on a five-point scale) in early June, triggered by a 32.3% plunge in the consensus earnings estimate over just one month — a dramatic downward revision. Meanwhile, 18 brokerages collectively rate the stock at 1.61, squarely between "Strong Buy" and "Buy," with twelve of them issuing the highest rating. Stifel recently lifted its price target from $110 to $132 and maintained its buy call, citing strong execution and rising revenue momentum. The divide between quantitative estimate revisions and qualitative broker sentiment could hardly be wider.

A key catalyst behind the bullish positioning is Rocket Lab's deepening relationship with the U.S. government. The company won a $90 million contract from the U.S. Space Force to build and operate two satellites for the Heimdall payload. Critically, this marks Rocket Lab's first gig as a prime contractor on a geostationary mission — a step up from being a component or launch supplier. The Space Development Agency's total commitments to the firm now exceed $1.3 billion, and the overall backlog stands at a record $2.2 billion. This shift from pure launch provider to full-service satellite and mission operator allows Rocket Lab to capture more value per contract, and investors are paying attention.

But the operational challenges haven't gone away. The workhorse Electron rocket keeps delivering regular launches — 31 new Electron and HASTE contracts were signed in the first quarter alone — but the real test is Neutron, the medium-lift vehicle slated for its maiden flight in the fourth quarter of 2026. Management has already secured five dedicated Neutron launch contracts, and acquisitions of Motiv Space Systems and Mynaric are strengthening vertical integration. The company finished Q1 with $1.2 billion in cash to fund development. Still, insider stock sales totaling $18 million have tempered some of the enthusiasm, even as the broader space sector gets a halo effect from the looming SpaceX IPO.

The stock itself has been a study in volatility. It closed at €104.20 on Thursday, up 5.47% on the day and 54.60% over the past month. Yet that remains 22.12% below the 52-week high of €133.80 touched on May 27. Over the most recent week, the shares lost nearly 16%, in a sharp reversal from the longer-term uptrend. The stock trades roughly 25% above its 50-day moving average and nearly 70% above its 200-day average — stretched by any measure. With an annualized 30-day volatility of 131.78%, the market is pricing in wild swings in both directions.

The next operational milestone is the launch of "The Grain Goddess Provides" mission for customer iQPS from Launch Complex 1, expected as early as June 2026. With more than 70 contracted missions on the manifest, demand is hardly the problem. The real question is whether rising revenue and expanding margins — analysts pencil in a 7.6% adjusted EBITDA margin by fiscal 2027 — can arrive fast enough to reverse the downward drift in profit forecasts. Until the earnings estimates stop falling, the stock's valuation will remain under pressure, no matter how many rockets lift off or satellites reach orbit.